GNRH1 and ovarian hyperstimulation syndrome: A meta-analysis by Pundir [6] showed that the incidence of moderate and severe OHSS was significantly lower in the GnRH antagonist group than in the GnRH agonist long protocol, while the incidence of severe OHSS was not significantly different.